D06.472.699.094

4 trials

Sponsors

Hospital do Coração/Associação do Sanatorio Sírio, Laboratório de Fisiologia do Exercício, Angitec, Universidade Federal de Ouro Preto

Conditions

HypertensionPhysical Functional PerformanceSedentary BehaviorSevere Infection with Sara-CoV-2

Phase 2

Treatment of severe COVID-19 with angiotensin-(1-7)

RecruitingRBR-35734p

AngitecSevere Infection with Sara-CoV-2

Start: 2020-08-05Updated: 2025-10-27

Phase 3

Assessment the Effect of Combined Treatment of diuretic 1.5mg/angiotensin receptor antagonists 50mg and diuretic 1.5mg/angiotensin receptor antagonists 100mg, Compared With 1.5 mg diuretic Monotherapy in the Treatment of Hypertension

Active, not recruitingRBR-2cnzk7

Hospital do Coração/Associação do Sanatorio SírioHypertension

Start: 2015-12-20Updated: 2025-10-27

Unknown Phase

Angiotensin- (1-7) supplementation in physical exercise practitioners

Active, not recruitingRBR-2nbmpbc

Laboratório de Fisiologia do ExercícioSedentary Behavior

Start: 2019-03-20Updated: 2025-10-27

Supplementation of Angiotensin-(1-7) formulations and their actions on physical performance and repair of muscle damage in recreational athletes and in physically active and sedentary people

RecruitingRBR-3bhkdg2

Universidade Federal de Ouro PretoPhysical Functional Performance

Start: 2024-03-28Updated: 2025-10-27

Related Papers

Effects of oral HPΒCD-angiotensin-(1-7) supplementation on recreational mountain bike athletes: a crossover study

The Physician and Sportsmedicine2023-02-082 citations